Product Information
SUMATRIPTAN-NAPROXEN 85-500 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $10.8442 per EA under NDC 65862092836. Its NADAC has been published 423 times since Jul 18, 2018.
FDA first approved this application on Feb 15, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500; 85 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862092836
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA207457FDA Approved
2/15/2018
TE Code
AB
On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has been published 423 times since Jul 18, 2018, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.8442 per EA |
|---|---|
| All-time high | $64.2190 (Nov 14, 2018) |
| All-time low | $10.8442 (Aug 19, 2026) |
| 52-week high | $19.8987 |
| 52-week low | $10.8442 |
| Median price | $22.0476 |
| Average price | $27.8135 |
| Largest weekly change | +47.6% (May 18, 2022) |
| Weeks tracked | 423 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUMATRIPTAN-NAPROXEN 85-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN-NAPROXEN 85-500 MG, manufactured by Aurobindo Pharma Limited, is $10.8442 per EA (NDC 65862092836), effective Aug 19, 2026.
How has the price of SUMATRIPTAN-NAPROXEN 85-500 MG changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has declined 77.6%. It has been tracked across 423 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN-NAPROXEN 85-500 MG?
Since Jul 18, 2018, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has ranged from a low of $10.8442 (Aug 19, 2026) to a high of $64.2190 (Nov 14, 2018), with a median of $22.0476 per EA.
Are there cheaper alternatives to SUMATRIPTAN-NAPROXEN 85-500 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN-NAPROXEN 85-500 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures SUMATRIPTAN-NAPROXEN 85-500 MG?
SUMATRIPTAN-NAPROXEN 85-500 MG (NDC 65862092836) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.